AI-generated summary
The authors report 270-day follow-up mycological data from a clinical trial of the Noveon laser for onychomycosis, a fungal nail infection. They found further decreases in positive fungal culture and microscopy, with 38% of the treated population classed as mycological cures across mild, moderate and severe disease. The abstract describes these as observational follow-up findings from a trial.
- Who or what was studied
- Patients with mild, moderate, or severe onychomycosis enrolled in a clinical trial of the Noveon laser
- Limits stated in the abstract
- The abstract does not state the total number of participants, and the follow-up findings are presented without a stated control group or comparison.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on mdpi.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.